Adam Laing is Co-Founder, President and Chief Scientific Officer of IMU Biosciences. A systems immunologist, Adam spent nearly a decade in Professor Adrian Hayday's group at King's College London and the Francis Crick Institute, leading large-scale human immune profiling programs across academic and industry partnerships. He co-founded IMU in 2021 to bring that work to patients. Adam holds a PhD in transplant immunology from King's College London.